Kylie Quinn, RMIT University and Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
The infection of a Victorian aged-worker who had received their first COVID vaccine dose isn’t completely surprising. We need two doses for optimal protection.
For now, it seems the benefits to Australia’s public health may be better served by other technology. And the public cost of maintaining the COVIDSafe app may not be in our collective interest.
This treatment would work by targeting the SARS-CoV-2 virus itself and stopping it in its tracks. The evidence we have so far is promising, but it’s still very early days.
There are many hard lessons learned from the pandemic; one is that our food system needs a serious reboot. Luckily, we need only look to nature’s cycles for clues on how to fix it.
Sam Jones, United Nations University and Finn Tarp, University of Copenhagen
The development strategy based on foreign investment in natural resources projects has not delivered economic growth or security. What’s needed is an inclusive vision based on local realities.
Answers to key questions about rare blood clots linked to AstraZeneca’s COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
The decision to cancel the games lies ultimately with the International Olympic Committee – an extraordinary power that explains why Tokyo is pressing ahead.
Brian Long, The University of Melbourne and Guy Morrow, The University of Melbourne
Melbourne’s snap-lockdown proves festivals are still vulnerable. If the government doesn’t provide insurance, arts organisations may decide it’s not worth the risk.
It’s an absolute priority we find and use ways to support kids to continue face-to-face learning in times of low community transmission, especially primary schools.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand